Perilipin-2 has been implicated in several metabolic, cardiovascular, and kidney diseases, including the demonstration of glomerular and tubular perilipin-2 in minimal change disease and diabetic glomerulosclerosis [28,29]. Here, PLIN2 is linked to lipoid nephrosis.